Annual report pursuant to Section 13 and 15(d)


4 Months Ended
Dec. 31, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (4,869,404)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in fair value of warrants 3,523,003
Offering costs allocated to warrant liabilities 972,230
Changes in operating assets and liabilities:  
Prepaid expenses (726,781)
Accrued expenses 428,433
Accounts payable 767,969
Due to related party 14,000
Net cash used in operating activities 109,450
Cash Flows from Investing Activities:  
Cash deposited in Trust Account (402,500,000)
Net cash used in investing activities (402,500,000)
Cash Flows from Financing Activities:  
Proceeds received from initial public offering, gross 402,500,000
Proceeds received from private placement 10,050,000
Payment of offering costs (1,065,273)
Underwriting discount (8,050,000)
Proceeds of note payable from related parties 127,448
Repayment of note payable from related parties (127,448)
Net cash provided by financing activities 403,434,727
Net increase in cash 1,044,177
Cash - beginning of the period 0
Cash - end of the period 1,044,177
Supplemental disclosure of noncash investing and financing activities:  
Offering costs included in accrued expenses 168,100
Deferred underwriting commissions in connection with the initial public offering 14,087,500
Formation and G&A costs paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000
Value of Class A ordinary shares subject to possible redemption $ 402,500,000